{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:00:28Z","timestamp":1753891228786,"version":"3.41.2"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Infection by the hepatitis C virus (HCV) is an important cause of chronic liver disease, considered a public health problem worldwide with high morbidity and mortality due to limited access to diagnostic tests in developing countries. Only a small percentage know their infection status and receive timely treatment. It is critical to make diagnostic tests for HCV infection accessible and to provide timely treatment, which not only reduces the spread of infection but also stops the progression of HCV disease without symptoms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine the prevalence of chronic infection by HCV in patients with risk factors by using rapid tests in Cartagena, Colombia, and describe their epidemiological characteristics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methodology<\/jats:title><jats:p>A cross-sectional descriptive observational study was carried out on asymptomatic adults with risk factors for HCV infection in the city of Cartagena between December 2017 and November 2019. A rapid immunochromatographic test was performed to detect antibodies, characterizing the population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 1,023 patients were identified who met the inclusion criteria, 58.5% women and 41.4% men, obtaining nine positive results, confirming chronic infection with viral load for HCV, finding seven cases of genotype 1b and two genotype 1a.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In our study, a prevalence of hepatitis C infection of 0.9% was found in asymptomatic individuals with risk factors, which allows us to deduce that the active search for cases in risk groups constitutes a pillar for the identification of the disease, the initiation of antiviral therapy, and decreased morbidity and mortality.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.814622","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T05:29:10Z","timestamp":1656912550000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of Chronic Infection by Hepatitis C Virus in Asymptomatic Population With Risk Factors in Cartagena, Colombia"],"prefix":"10.3389","volume":"9","author":[{"given":"Pedro","family":"Imbeth-Acosta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Leal-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Ramos-Clason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nehomar","family":"P\u00e1jaro-Galvis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Cristina","family":"Mart\u00ednez-\u00c1vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amilkar","family":"Almanza-Hurtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1s","family":"Rodr\u00edguez-Yanez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Bermudez-Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Vergara-Serpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Abuabara-Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Raad-Sarabia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika Patricia","family":"Villar-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffany Isabel","family":"Tatis-Geney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Adolfo","family":"Collazos-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Rico-Fontalvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Daza-Arnedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"P\u00e9rez-Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huber","family":"Alvarado-Castell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel Hernando","family":"L\u00f3pez Acu\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Blach","year":"2017","journal-title":"Lancet Gastroenterol Hepatol."},{"volume-title":"Global Hepatitis Report 2017","year":"2017","key":"B2"},{"key":"B3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.22516\/25007440.222","article-title":"Hepatitis C: una aproximaci\u00f3n cl\u00ednica y epidemiol\u00f3gica en Cali, Colombia","volume":"33","author":"Rojas Rodr\u00edguez","year":"2018","journal-title":"Rev Colomb Gastroenterol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s40471-017-0108-x","article-title":"Hepatitis C: review of the epidemiology, clinical care, and continued challenges in the direct-acting antiviral era","volume":"4","author":"Millman","year":"2017","journal-title":"Curr Epidemiol Rep."},{"key":"B5","unstructured":"352019"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/S1386-6532(05)80032-0","article-title":"Hepatitis C virus seroprevalence in multi-transfused patients in Colombia","volume":"34","author":"Beltr\u00e1n","year":"2005","journal-title":"J Clin Virol."},{"key":"B7","first-page":"26","article-title":"Epidemiology and risk factors for hepatitis C virus genotypes in a high prevalence region in Italy","volume":"41","author":"Buonomo","year":"2018","journal-title":"New Microbiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.cmi.2016.07.035","article-title":"Hepatitis C: global epidemiology and strategies for control","volume":"22","author":"Lanini","year":"2016","journal-title":"Clin Microbiol Infect."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","article-title":"Hepatitis C","volume":"394","author":"Spearman","year":"2019","journal-title":"Lancet."},{"key":"B10","unstructured":"Epidemiolog\u00eda y factores de riesgo711\n            Prieto Ort\u00edzJE\n            Restrepo Guti\u00e9rrezJC\n          Rev Colomb Gastroenterol282013"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Glob Heal."},{"key":"B12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1071\/SH17168","article-title":"Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: results from a prospective study","volume":"15","author":"Gentile","year":"2018","journal-title":"Sex Health."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/infdis\/jiy401","article-title":"Identification of a novel hepatitis C virus genotype from Punjab, India: expanding classification of hepatitis C virus into 8 genotypes","volume":"218","author":"Borgia","year":"2018","journal-title":"J Infect Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1478-3231.2011.02538.x","article-title":"Trends and projections of hepatitis C virus epidemiology in Latin America","volume":"31","author":"Kershenobich","year":"2011","journal-title":"Liver Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/j.1572-0241.2000.01854.x","article-title":"Epidemiology of hepatitis C virus infection in American veterans","volume":"95","author":"Cheung","year":"2000","journal-title":"Am J Gastroenterol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.7705\/biomedica.v37i1.3173","article-title":"Genotipos circulantes del virus de la hepatitis C en Colombia","volume":"37","author":"Santos","year":"2017","journal-title":"Biomedica"},{"key":"B17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cmi.2016.01.009","article-title":"Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care","volume":"22","author":"Chevaliez","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"B18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL recommendations on treatment of hepatitis C 2018","volume":"69","author":"Pawlotsky","year":"2018","journal-title":"J Hepatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1186\/s12879-017-2765-2","article-title":"WHO guidelines on testing for hepatitis B and C - meeting targets for testing","volume":"17","author":"Hellard","year":"2017","journal-title":"BMC Infect Dis."},{"volume-title":"WHO Guidelines on Hepatitis B and C Testing","year":"2017","key":"B20"},{"key":"B21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jcv.2018.12.008","article-title":"Demonstration of the diagnostic agreement of capillary and venous blood samples, using hepatitis-C virus SD Bioline\u00a9 rapid test: a clinic-based study","volume":"111","author":"Sun","year":"2019","journal-title":"J Clin Virol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jviromet.2018.08.019","article-title":"Performance of a new rapid diagnostic test for the detection of antibodies to hepatitis C virus","volume":"261","author":"Poiteau","year":"2018","journal-title":"J Virol Methods."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0210556","article-title":"Evaluation of five rapid diagnostic tests for detection of antibodies to hepatitis C virus (HCV): a step towards scale-up of HCV screening efforts in India","volume":"14","author":"Mane","year":"2019","journal-title":"PLoS ONE."},{"key":"B24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1615\/CritRevEukaryotGeneExpr.2018025062","article-title":"Evaluation of three rapid screening tests for detection of hepatitis C antibodies on mass scale","volume":"29","author":"Waheed","year":"2019","journal-title":"Crit Rev Eukaryot Gene Expr."},{"key":"B25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11739-019-02163-8","article-title":"Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study","volume":"15","author":"Di Minno","year":"2020","journal-title":"Intern Emerg Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s40620-019-00608-z","article-title":"Interferon-free regimens improve kidney function in patients with chronic hepatitis C infection","volume":"32","author":"Coppola","year":"2019","journal-title":"J Nephrol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","article-title":"Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection","volume":"370","author":"Afdhal","year":"2014","journal-title":"N Engl J Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","article-title":"Sofosbuvir and velpatasvir for hcv genotype 1, 2, 4, 5, and 6 infection","volume":"373","author":"Feld","year":"2015","journal-title":"N Engl J Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1056\/NEJMoa1512612","article-title":"Sofosbuvir and velpatasvir for HCV Genotype 2 and 3 infection","volume":"373","author":"Foster","year":"2015","journal-title":"N Engl J Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1056\/NEJMoa1512614","article-title":"Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis","volume":"373","author":"Curry","year":"2015","journal-title":"N Engl J Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/hep.28473","article-title":"Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: a randomized phase III study (ALLY-3+)","volume":"63","author":"Leroy","year":"2016","journal-title":"Hepatology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1056\/NEJMoa1613512","article-title":"Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection","volume":"376","author":"Bourli\u00e8re","year":"2017","journal-title":"N Engl J Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1053\/j.gastro.2016.09.045","article-title":"Effectiveness of elbasvir and grazoprevir combination, with or without ribavirin, for treatment-experienced patients with chronic hepatitis C infection","volume":"152","author":"Kwo","year":"2017","journal-title":"Gastroenterology"},{"key":"B34","unstructured":"562016"},{"key":"B35","doi-asserted-by":"publisher","first-page":"w14544","DOI":"10.4414\/smw.2017.14544","article-title":"Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade","volume":"147","author":"Bregenzer","year":"2017","journal-title":"Swiss Med Wkly."},{"key":"B36","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S2468-1253(17)30086-9","article-title":"Rapid HCV RNA testing: removing the final obstacle to elimination","volume":"2","author":"Cooper","year":"2017","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1053\/j.gastro.2018.01.035","article-title":"Glecaprevir\/pibrentasvir: the final piece in the hepatitis C virus treatment puzzle?","volume":"154","author":"Aghemo","year":"2018","journal-title":"Gastroenterology."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e18888","DOI":"10.1371\/journal.pone.0018888","article-title":"Hepatitis B (HBV), hepatitis C (HCV) and hepatitis delta (HDV) viruses in the Colombian population-how is the epidemiological situation?","volume":"6","author":"Alvarado-Mora","year":"2011","journal-title":"PLoS ONE."},{"key":"B39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.22516\/25007440.50","article-title":"Determinaci\u00f3n de la prevalencia de hepatitis C mediante la prueba r\u00e1pida BIOLINE HCV en una poblaci\u00f3n de alto riesgo","volume":"30","author":"Mart\u00ednez","year":"2015","journal-title":"Rev Colomb Gastroenterol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/1743-422X-9-242","article-title":"Molecular characterization of hepatitis c virus in multi-transfused Colombian patients","volume":"9","author":"Di Filippo","year":"2012","journal-title":"Virol J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.drugpo.2018.07.002","article-title":"Prevalence of hepatitis C virus in young people who inject drugs in four Colombian cities: a cross-sectional study using Respondent Driven Sampling","volume":"60","author":"Toro-Tob\u00f3n","year":"2018","journal-title":"Int J Drug Policy."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1002\/jmv.21908","article-title":"Molecular characterization, distribution, and dynamics of hepatitis C virus genotypes in blood donors in Colombia","volume":"82","author":"Mora","year":"2010","journal-title":"J Med Virol."},{"key":"B43","unstructured":"1192019"},{"key":"B44","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/10826084.2019.1683198","article-title":"Prevalence of HIV\/hepatitis C virus co-infection and injection risk correlations in people who inject drugs in Colombia: a cross-sectional study using respondent driven sampling","volume":"55","author":"Toro-Tob\u00f3n","year":"2020","journal-title":"Subst Use Misuse."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.814622\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T05:29:15Z","timestamp":1656912555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.814622\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,4]]},"references-count":44,"alternative-id":["10.3389\/fmed.2022.814622"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.814622","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2022,7,4]]},"article-number":"814622"}}